Abstract
Patients with sickle cell disease (SCD) require multiple transfusions with red blood cell (RBC) components, which exposes them to numerous, possible foreign antigens and potentially causes them to produce an antibody or antibodies to the antigens they lack. Once a clinically significant antibody is produced, units of RBCs that lack the associate antigens should be transfused. As previous…